Chase AIPricingFAQs
Display currency
Loading news…

Ollin Biosciences

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Austin, Texas, United States Founded 2023 11-50 employees For Profit

Ollin Biosciences develops ophthalmic therapies focused on treating serious vision-threatening diseases.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
2

Company Info

Founded
2023
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
News articles
37
HQ
Austin, Texas, United States
Region
Southern US

Signals & Scores

Heat score
High
Growth score
High
Trend (7d)
-0.5
Trend (30d)
9.8
Trend (90d)
9.8
Last leadership hire
Jun 24, 2026

Key People at Ollin Biosciences

Co-Founder
CEO & Co-Founder

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Ollin Biosciences

Loading news…

FAQs about Ollin Biosciences

People who checked this page also checked these

Browse the full Acquirezy directory.
Ollin Biosciences - Company Profile, Full Acquisitions List, Funding and Investments